Vaxil Bio Ltd. announced that effective July 31, 2023, in order to reduce costs and preserve cash, Dr. Yuval Avnir, the Company?s CEO will be replaced by Mr. Gadi Levin, the Company?s current chairperson of the board and CFO. Dr. Avnir will continue to provide consulting services to the Company, according to his availability, and as needed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | 0.00% | -40.00% |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 1.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VXL Stock
- News Vaxil Bio Ltd.
- Vaxil Bio Ltd. Announces CEO Changes